Platelet function test HemoSTATUS 2: tool or toy for an optimized management of hemostasis?

Abstract

Background: Bleeding after open heart surgery is a common but unintended problem, which is unequivocally related to platelet function. The target of our study was to correlate platelet activation levels and postoperative blood loss as well as the predictive power of measurements focusing on postoperative hemostasis.

Materials and methods: The prospective trial comprised 100 patients (mean age: 64.3 years, 68% male) undergoing cardiac surgery. Platelet activation was measured by the new and modified HemoSTATUS™ test. Blood samples were drawn pre-, intra- and postoperatively. Standard hemostasis tests, including activated clotting time (ACT), partial thromboplastin time (PTT), hemoglobin, platelet count, antithrombin III (AT III) and fibrinogen, were measured according to the clinical routine. Blood loss and consumed blood products were documented up to the 24th hour after the operation.

Results: Platelet activation showed a typical change, with lowest levels after the end of extracorporeal circulation and a restitution to preoperative levels after 24 h. Mean blood loss was 461 ml. Statistical analysis showed neither a correlation to the platelet activation measurements nor to low pre-, intra- or postoperative levels.

Conclusion: The HemoSTATUS platelet function test is not suitable for a reliable monitoring of platelet pathophysiology and patient outcome after extracorporeal circulation. Furthermore, no correlation of preoperative platelet activation and blood loss could be shown.

Get full access to this article

View all access options for this article.

References

Woodman RC , Harker LA. Bleeding complications associated with cardiopulmonary bypass . Blood 1990; 76: 1680-1697 .

Ray MJ , Hawson GA , Just SJ. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass . Ann Thorac Surg 1994; 57: 981-986 .

Spiess BD. The contribution of fibrinolysis to postbypass bleeding . J Cardiothorac Vasc Anesth 1991; 5: 13-17 .

Rinder CS , Bohnert J , Rinder HM , Mitchell J , Ault K , Hillman R. Platelet activation and aggregation during cardiopulmonary bypass . Anesthesiology 1991; 75: 388-389 .

Brister SJ , Ofosu FA , Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant ? Thromb Haemostasis 1993; 70: 259-262 .

Boyle EM , Verrier ED , Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response . Ann Thorac Surg 1996; 62: 1549-1557 .

Surgenor DM , Churchill WH , Wallace EL et al. Determinants of red cell, platelet, plasma precipitate transfusions during coronary artery graft surgery: the collaborative hospital transfusion study . Transfusion 1996; 36: 521-532 .

Ammar T , Reich DL. Bedside coagulation monitoring [editorial] . J Cardiothorac Vasc Anesth 1995; 9: 353-354 .

Despotis GJ , Levine V , Filos KS et al. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients . Anesthesiology 1996; 85: 1311-1323 .

10.

Ereth MH , Nuttall GA , Klindworth JT et al. Does the platelet-activated clotting test [HemoSTATUS] predict blood loss and platelet dysfunction associated with cardiopulmonary bypass ? Anesth Analg 1997; 85: 259-264 .

11.

Shore-Lesserson L , Fisher C , Ammar T , Sarrer K , De Pario M. Comparison of HemoSTATUS with flow cytometric analysis of platelet function during cardiac surgical procedures . Anesth Analg 1997; 84: 177-177 .

12.

Despotis GJ , Levine V , Saleen R , Spitznagel E , Joist JH. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial . Lancet 1999; 10: 106-110 .

13.

Ereth MH , Nutall GA , Salsach BJ , Klidworth JT , Oliver WC Jr , Schatt HV. The relation between the platelet-activated clotting test [HemoSTATUS] and blood loss after cardiopulmonary bypass . Anesthesiology 1998; 88: 962-969 .

14.

Harker LA , Malpass TW , Branson HE , Hessel EA , Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective agranular release . Blood 1980; 56: 824-834 .

15.

Bick RL. Hemostasis defects associated with cardiac surgery prosthetic devices and other extracorporeal circuits . Thromb Hemostasis 1985; 11: 249-280 .

16.

Goodnough LT , Soegiarso RW , Birkmeyer JD , Welch HG. Economic impact of inappropriate blood transfusion in CABG surgery . Am J Med 1993; 94: 962-969 .

17.

Coiffic A , Cazes E , Forestier F , Lanza F , Nurden A , Nurden P. Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the HemoSTATUS . Thromb Res 1999; 95: 83-91 .